141 related articles for article (PubMed ID: 27546038)
1. Best Matching Protein Conformations and Docking Programs for a Virtual Screening Campaign Against SMO Receptor.
Amendola G; Di Maio D; La Pietra V; Cosconati S
Mol Inform; 2016 Sep; 35(8-9):340-9. PubMed ID: 27546038
[TBL] [Abstract][Full Text] [Related]
2. Deciphering structural stability and binding mechanisms of potential antagonists with smoothened protein.
Sinha N; Chowdhury S; Sarkar RR
J Biomol Struct Dyn; 2018 Aug; 36(11):2917-2937. PubMed ID: 28849750
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays.
Lu W; Zhang D; Ma H; Tian S; Zheng J; Wang Q; Luo L; Zhang X
Eur J Med Chem; 2018 Jul; 155():34-48. PubMed ID: 29857275
[TBL] [Abstract][Full Text] [Related]
4. Structural optimization on a virtual screening hit of smoothened receptor.
Song S; Jiang J; Zhao L; Wang Q; Lu W; Zheng C; Zhang J; Ma H; Tian S; Zheng J; Luo L; Li Y; Yang ZJ; Zhang X
Eur J Med Chem; 2019 Jun; 172():1-15. PubMed ID: 30939349
[TBL] [Abstract][Full Text] [Related]
5. State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures.
Espinosa-Bustos C; Mella J; Soto-Delgado J; Salas CO
Future Med Chem; 2019 Mar; 11(6):617-638. PubMed ID: 30912670
[TBL] [Abstract][Full Text] [Related]
6. MTiOpenScreen: a web server for structure-based virtual screening.
Labbé CM; Rey J; Lagorce D; Vavruša M; Becot J; Sperandio O; Villoutreix BO; Tufféry P; Miteva MA
Nucleic Acids Res; 2015 Jul; 43(W1):W448-54. PubMed ID: 25855812
[TBL] [Abstract][Full Text] [Related]
7. Comparative performance of several flexible docking programs and scoring functions: enrichment studies for a diverse set of pharmaceutically relevant targets.
Zhou Z; Felts AK; Friesner RA; Levy RM
J Chem Inf Model; 2007; 47(4):1599-608. PubMed ID: 17585856
[TBL] [Abstract][Full Text] [Related]
8. A Comparison between Enrichment Optimization Algorithm (EOA)-Based and Docking-Based Virtual Screening.
Spiegel J; Senderowitz H
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008467
[TBL] [Abstract][Full Text] [Related]
9. Molecular Modelling of Berberine Derivatives as Inhibitors of Human Smoothened Receptor and Hedgehog Signalling Pathway Using a Newly Developed Algorithm on Anti-Cancer Drugs.
Kaboli PJ; Bazrafkan M; Ismail P; Ling KH
Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):384-400. PubMed ID: 28969581
[TBL] [Abstract][Full Text] [Related]
10. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance.
Perola E; Walters WP; Charifson PS
Proteins; 2004 Aug; 56(2):235-49. PubMed ID: 15211508
[TBL] [Abstract][Full Text] [Related]
11. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor.
Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M
FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740
[TBL] [Abstract][Full Text] [Related]
12. Choosing the Optimal Rigid Receptor for Docking and Scoring in the CSAR 2013/2014 Experiment.
Baumgartner MP; Camacho CJ
J Chem Inf Model; 2016 Jun; 56(6):1004-12. PubMed ID: 26222931
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Virtual Screening.
Li Q; Shah S
Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
[TBL] [Abstract][Full Text] [Related]
14. Ligand-based 3D pharmacophore modeling, virtual screening, and molecular dynamic simulation of potential smoothened inhibitors.
Mohebbi A
J Mol Model; 2023 Apr; 29(5):143. PubMed ID: 37062794
[TBL] [Abstract][Full Text] [Related]
15. Docking and Virtual Screening in Drug Discovery.
Kontoyianni M
Methods Mol Biol; 2017; 1647():255-266. PubMed ID: 28809009
[TBL] [Abstract][Full Text] [Related]
16. Flexi-pharma: a molecule-ranking strategy for virtual screening using pharmacophores from ligand-free conformational ensembles.
Lans I; Palacio-Rodríguez K; Cavasotto CN; Cossio P
J Comput Aided Mol Des; 2020 Oct; 34(10):1063-1077. PubMed ID: 32656619
[TBL] [Abstract][Full Text] [Related]
17. Protein flexibility in ligand docking and virtual screening to protein kinases.
Cavasotto CN; Abagyan RA
J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
[TBL] [Abstract][Full Text] [Related]
18. Virtual screening-based discovery and mechanistic characterization of the acylthiourea MRT-10 family as smoothened antagonists.
Manetti F; Faure H; Roudaut H; Gorojankina T; Traiffort E; Schoenfelder A; Mann A; Solinas A; Taddei M; Ruat M
Mol Pharmacol; 2010 Oct; 78(4):658-65. PubMed ID: 20664000
[TBL] [Abstract][Full Text] [Related]
19. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking.
Scarpino A; Ferenczy GG; Keserű GM
Methods Mol Biol; 2021; 2266():73-88. PubMed ID: 33759121
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE-225 and LEQ-506.
Tu J; Li JJ; Song LT; Zhai HL; Wang J; Zhang XY
Pharmacol Res; 2018 Mar; 129():491-499. PubMed ID: 29175550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
